 |
|
New compound effectively treats fungal infections
June 25, 2007A new mechanism to attack hard-to-treat fungal infections has been revealed by scientists from the biotech company Anacor Pharmaceuticals Inc., California, and the European Molecular Biology Laboratory [EMBL] outstation in Grenoble, France. In the current issue of Science they describe how a new compound kills fungal pathogens by blocking an enzyme crucial for their protein synthesis.
The human body is home to many different kinds of fungi. While the majority normally do not harm us, some fungi can cause unpleasant infections of skin, nails or lungs.
"We have discovered a new compound that has the potential to treat common chronic nail infections caused by fungi," says Dickon Alley, researcher at Anacor Pharmaceuticals. "The compound, called AN2690, kills fungi by blocking their ability to make proteins. It has been very successful in clinical trials." AN2690 interferes with an enzyme called leucyl-tRNA synthetase, which is involved in translation, one of the last steps in the process of turning a gene's DNA code into a protein. The process begins when the cell makes an RNA version of the gene's code, called messenger RNA. Ribosomes, the cell's protein synthesis machinery, then translate the messenger RNA into protein by stitching together the amino acids in the order specified by the message. This requires the help of molecules called tRNAs, which link the code of the messenger RNA to the correct amino acid.
Leucyl-tRNA synthetase is one of a group of enzymes called aminoacyl-tRNA synthetases that attach the correct amino acid to each tRNA. Some of these enzymes have two main functional parts, or active sites: a site that links the amino acid to the tRNA, and a separate editing site that proofreads this process and removes wrongly added amino acids.
To find out how exactly AN2690 blocks leucyl-tRNA synthetase Stephen Cusack, Head of EMBL Grenoble, and his team generated crystals of the enzyme bound to tRNA in the presence of AN2690. Examining them with the high-intensity X-ray source at the European Synchrotron Radiation Facility, Cusack and his colleagues found that AN2690 sticks in the editing site of the enzyme where it makes a very strong bond to the end of the tRNA, trapping it on the enzyme. This stops the enzyme working and thus blocks protein synthesis, killing the fungal cell. The mechanism crucially depends on a boron atom that is part of AN2690, which is needed to link the compound to the tRNA. It is the first time that scientists describe such a mechanism, suggesting boron containing compounds as a promising new class of drug candidates.
"Now that we know how AN2690 works, the same approach could be adapted to target other aminoacyl-tRNA synthetases with editing sites and also other pathogenic microbes," concludes Cusack. "We are now working towards finding related antibacterial compounds that could help counter the problem of antibiotic resistance."
European Molecular Biology Laboratory
Leucyl-tRNA synthetase is one of a group of enzymes called aminoacyl-tRNA synthetases that attach the correct amino acid to each tRNA. Some of these enzymes have two main functional parts, or active sites: a site that links the amino acid to the tRNA, and a separate editing site that proofreads this process and removes wrongly added amino acids.
To find out how exactly AN2690 blocks leucyl-tRNA synthetase Stephen Cusack, Head of EMBL Grenoble, and his team generated crystals of the enzyme bound to tRNA in the presence of AN2690. Examining them with the high-intensity X-ray source at the European Synchrotron Radiation Facility, Cusack and his colleagues found that AN2690 sticks in the editing site of the enzyme where it makes a very strong bond to the end of the tRNA, trapping it on the enzyme. This stops the enzyme working and thus blocks protein synthesis, killing the fungal cell. The mechanism crucially depends on a boron atom that is part of AN2690, which is needed to link the compound to the tRNA. It is the first time that scientists describe such a mechanism, suggesting boron containing compounds as a promising new class of drug candidates.
"Now that we know how AN2690 works, the same approach could be adapted to target other aminoacyl-tRNA synthetases with editing sites and also other pathogenic microbes," concludes Cusack. "We are now working towards finding related antibacterial compounds that could help counter the problem of antibiotic resistance."
European Molecular Biology Laboratory
Fungal Infection Current Events and Fungal Infection News RSSWPI Researchers Take Aim at Hard-to-Treat Fungal Infections
A team of researchers at the Worcester Polytechnic Institute (WPI) Life Sciences and Bioengineering Center at Gateway Park has developed a new model system to study fungal infections.
Genetic links to fungal infection risk identified
Two genetic mutations that may put individuals at increased risk of fungal infections have been identified by scientists from UCL and Radboud University, increasing understanding about the genetic basis of these infections and potentially aiding the development of new treatments.
Breast cancer drug shows promise against serious infections
An FDA-approved drug used for preventing recurrence of breast cancer shows promise in fighting life-threatening fungal infections common in immune-compromised patients, such as infants born prematurely and patients with cancer.
Fungi the cause of many outbreaks of disease but mostly ignored
Fungi can cause a number of life-threatening diseases but they also are becoming increasingly useful to science and manufacturing every year.
Predicting the risk of a common fungal infection after stem cell transplantation
In silico genetic analysis in mice has led to the discovery of a gene affecting susceptibility to a severe fungal infection in transplant recipients.
New findings on immune system in amphibians
Krakow/Halle. Major Histocompatibility Complex (MHC) genes produce proteins that are crucial in fighting pathogen assault. Researchers from the Jagiellonian University in Krakow and from the Helmholtz Centre for Environmental Research (UFZ) characterized genetic variation and detected more than one MHC class II locus in a tailed amphibian.
Pregnancy may slow -- not accelerate -- progression to AIDS
A new study may help put to rest fears that pregnancy accelerates progression to full-blown AIDS in women with HIV receiving antiretroviral therapy.
Anti-fungal drug stops blood vessel growth
Researchers at Johns Hopkins have discovered to their surprise that a drug commonly used to treat toenail fungus can also block angiogenesis, the growth of new blood vessels commonly seen in cancers.
Insects cultivate 'antibiotic-producing bacteria' in their antennae
Bacteria live in, on and around us and other organisms with sometimes very beneficial results. For the first time scientists have shown that one species of insect deliberately cultivates bacteria in its antennae in order to protect their larvae from fungal attack.
Infectious disease researchers develop basis for experimental melanoma treatment
While investigating a fungus known to cause an infection in people with AIDS, two grantees of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), unexpectedly discovered a potential strategy for treating metastatic melanoma, one of the deadliest forms of skin cancer.
More Fungal Infection Current Events and Fungal Infection News Articles
 |
Fungal Infection: Diagnosis and Management by Malcolm Richardson (Author), David W. Warnock (Author) Second author, David W. Warnock, is with the Centers for Disease Control and Prevention, Atlanta, GA. Current guide to the clinical manifestations, laboratory diagnosis and management of superficial, subcutaneous, and systemic fungal infections. Previous edition: c1997. For practitioners and residents. Softcover. DNLM: Mycoses--therapy. |
 |
Pocket Guide to Fungal Infection by Malcolm Richardson (Author), Elizabeth Johnson (Author) The Pocket Guide to Fungal Infection presents, in a convenient and practical format, the major features of fungal infections in humans, providing visual information for each pathogen and the infections they cause.
The second edition has been extensively revised. In each chapter the clinical manifestations and management sections have been revised and updated to include recently developed antifungal drugs. New sections include;
Emerging yeast and filamentous fungal pathogens Antifungal susceptibility testing Antifungal assays Molecular methods in medical mycology Mycological aspects of the indoor environment.
Medical... |
 |
Contemporary Diagnosis and Management of Fungal Infections by Jack D. Sobel (Author), MD (Author) The rising incidence of fungal infections, especially among hospitalized patients, makes this handbook a must-read text for clinicians. Expertly organized for quick review, this handbook is written by two outstanding infectious disease specialists. Full-color inserts are included. |
 |
Monistat Vaginal Antifungal Medication 1- day , 0.16-Ounce Prefilled Applicators (Pack of 2) by Monistat Tioconazole Ointment (6.5%). 1 Ready-To-Use Prefilled Applicator. Cures most vaginal yeast infections. This product is a 1-dose treatment, most women do not experience complete relief of their symptoms in just one day. Most women experience some improvement within one day and complete relief of symptoms within 7 days. |
 |
Ring-Ex - Natural Pet Ringworm Relief - Fungal Skin Infections Treatment (30ml) by Nativeremedies Ringworm may cause various lesions on the skin and these are not always in the shape of a ring. You may notice your pet scratching at areas that look scaly and inflamed and, with time, the hair in these patches may be lost. Ringworm can look very similar to a number of other skin conditions including mange and allergic conditions, so if in doubt it is important to take your pet to a vet in order to be sure of the diagnosis. Usual treatment of ringworm involves use of anti-fungal shampoos or creams. In severe cases oral anti-fungal medication may be used but this has the potential to cause side-effects. PetAlive Ring-Ex contains a blend of natural, herbal ingredients in a medicinal olive oil base, all specially selected to treat ringworm infections. Ring-Ex will also help to prevent the... |
 |
Fungal Infections in the Immunocompromised Patient (Infectious Disease and Therapy) by John R. Wingard (Editor), Elias Anaissie (Editor) Unlike any other source on the subject, Fungal Infections in the Immune-Compromised provides an up-to-date account of fungal syndromes in immunocompromised patients and provides expert descriptions of their clinical manifestations and settings in which they cause illness. It covers the pros and cons of current and emerging diagnostic measures, techniques to incorporate new diagnostic tools and treatments into established clinical practices, and the most recent therapeutic strategies in patient care. The book supplies practical tools in the form of algorithms, slides, graphs, figures, photographs, and radiographs to assist in recognition and management of fungal illnesses. |
 |
Fungal Infection (Tinea Versicolor) Stay Young for Life (Primary Contributor) |
 |
Oregano Oil: Nature's Answer to Bacterial, Viral, and Fungal Infection (Woodland Health) by Candace Salima (Author) Oregano Oil has been proven to assist in the eradication of a number of pesky health problems that plague most people at some point in their lives. It functions as an antibacterial, antifungal, and antiviral agent, and is a very powerful antiseptic, safe for both internal and external use. Oregano oil also contains powerful agents that aid in the destruction or elimination of parasitic organisms. Oregano oil can help with a host of everyday health problems. |
 |
Zeasorb-AF Antifungal Drying Gel (0.85 oz) by Zeasorb Zeasorb-AF Antifungal Drying Gel is a targeted treatment for athlete's foot, jock itch, and ringworm in hard-to-reach areas is easy! It applies as a gel and instantly dries to a soft powdery finish. Antifungal medication works to relieve symptoms, while the powdery finish soothes chafing and keeps skin dry and comfortable. |
 |
Manuka Oil 5mL by Borbonese Perfume Manuka is a purifying and clarifying, fresh, herbal-sweet Essential Oil. It is used in diffuser, for skin care (acne), aroma baths and for compresses. Often used for acne, infections, candida, fungal infections and eczema. |
| © 2009 BrightSurf.com |